
0:00
24:27
MIBC Treatment Landscape
Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Jen-Jane Liu, MD, FACS
CME Available: auau.auanet.org/node/44077
ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson
LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Integrate immunotherapy and targeted therapy into the multimodal management of MIBC, selecting appropriate regimens and sequencing strategies based on current guidelines, clinical trial data, and patient-specific factors.
2. Evaluate the clinical role, mechanisms of action, and evidence base for targeted therapies in MIBC, including biomarker-driven selection to support personalized treatment planning.
3. Develop and apply practical approaches for preventing, monitoring, and managing immune-related adverse events and other toxicities associated with immunotherapy and targeted therapy to optimize patient safety, adherence, and quality of life.
Fler avsnitt från "AUAUniversity"



Missa inte ett avsnitt av “AUAUniversity” och prenumerera på det i GetPodcast-appen.







